Tony Jones

@tony_biotech

CEO of One Nucleus with a strong belief in the people factor of doing business. expressed views are my own. retweets indicate interest rather than agreement

London
Vrijeme pridruživanja: kolovoz 2013.

Tweetovi

Blokirali ste korisnika/cu @tony_biotech

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @tony_biotech

  1. proslijedio/la je Tweet

    Parkinson’s Concierge are proud to be involved with WPP Health Practice. We know together we can make a difference to all those affected by Parkinson’s We are always creating awareness outside of the Parkinson’s Community and have done this so far by Pa…

    Poništi
  2. proslijedio/la je Tweet
    prije 18 sati

    Syncona hosted a Capital Markets Day yesterday which included a deep dive into Syncona's Generation 2 companies, Freeline, Gyroscope and Achilles. If you missed it, you can watch it back here:

    Poništi
  3. proslijedio/la je Tweet
    prije 14 sati

    Find out what we're up to in this month's edition of eNews:

    Poništi
  4. proslijedio/la je Tweet
    prije 16 sati

    In collaboration with this session will cover the trends in flexible working from a company perspective and will bring the legal insights on how to practically make it work for the employers and employees. Find out more here:

    Poništi
  5. proslijedio/la je Tweet

    East of England firms urged to enter EY Entrepreneur of the Year Awards

    Poništi
  6. proslijedio/la je Tweet

    We're delighted to be part of this thriving region with

    Poništi
  7. proslijedio/la je Tweet

    Great blog post for : "Let’s get set to fire up more Degree Apprenticeships." Great blog from Dr Malcom Skingle, Chair of the SIP, on . Read it here:

    Poništi
  8. proslijedio/la je Tweet
    4. velj

    Gilead preparing a trial in China of remdesivir to treat 2019-nCoV: . Meanwhile, at least 9 trials of #2019-nCoV therapies are underway. All BioCentury coverage of the outbreak is in front of the paywall at .

    Poništi
  9. proslijedio/la je Tweet
    4. velj
    Poništi
  10. proslijedio/la je Tweet
    4. velj

    The Paris Region cluster consists of 300+ companies, 200+ companies and 360+ medical technology companies. Download here to learn more about the health tech hub >>

    Poništi
  11. proslijedio/la je Tweet
    4. velj

    Great to meet the new cohort tonight. We’ve got high expectations of you ...

    Poništi
  12. proslijedio/la je Tweet
    4. velj

    East of England region dominates UK biotech venture capital deals

    Poništi
  13. proslijedio/la je Tweet
    4. velj

    Join us in London for a discussion on the main take-outs and commentary on the deal-making that took place at . Find out more here:

    Poništi
  14. proslijedio/la je Tweet
    4. velj

    We're looking to recruit two enthusiastic Research Associates to work in our Lead Isolation Group. The job description is here: If you'd like to apply send your CV with covering letter to info@crescendobiologics.com. Look forward to hearing from you.

    Poništi
  15. proslijedio/la je Tweet
    4. velj

    Numbers keep driving upwards as currently there are 20,630 confirmed cases worldwide, including 427 fatalities. Tracking coronavirus: Map, data and timeline -

    Poništi
  16. proslijedio/la je Tweet
    4. velj

    The pharma industry, the Government and the NHS have a Voluntary Scheme which caps how much the NHS spends on new medicines. explains what this means for the NHS

    Poništi
  17. proslijedio/la je Tweet
    3. velj

    Delighted to welcome on-board Dr Kenji Hashimoto as our Chief Medical Officer. Dr Hashimoto will oversee Crescendo’s clinical development strategy and medical affairs as we focus on bringing our lead programme CB307 (4-1BB x PSMA bispecific ) to the clinic this year.

    Poništi
  18. proslijedio/la je Tweet
    3. velj

    A warm welcome to Laura Boyd starting today as Deputy Director for - helping and others to prevent heart attacks and strokes at scale

    Poništi
  19. proslijedio/la je Tweet
    3. velj

    We’re pleased to welcome Dr Catherine Beech OBE and Dr Benedict Cross to the team as Non-Executive Director and Senior Director (Technology) respectively. Find out more about our new at:

    Poništi
  20. proslijedio/la je Tweet
    3. velj

    we are now open for nominations for EY Entrepreneur Of The Year 2020 UK! Nominate an for the latest edition of the programme at

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·